Current evidence on interactions between the microbiome and therapies for allergic diseases, focusing on antihistamines, corticosteroids, leukotriene receptor antagonists, and biologic agents is summarized.
Miljana Poparić, Borko Milanovic, David Strilić et al.· Microbiology Research· 0 citations
The analysis identified the main barriers responsible for low oral bioavailability of peptide drugs, as well as promising approaches to overcoming these obstacles, including peptide modification, enzyme inhibition, permeation enhancement, mucolytic strategies, and advanced carrier systems.
Sara Vasović, Lucija V. Vasović, Nikola Martić et al.· Pharmaceuticals· 0 citations
This narrative review synthesizes contemporary evidence on the contribution of the gut microbiota to the pathogenesis of metabolic syndrome and T2DM and critically examines bidirectional interactions between the microbiome and antidiabetic therapy within the framework of pharmacomicrobiomics.
David Strilić, Bojan Stanimirov, Nebojša Pavlović et al.· Frontiers in Pharmacology· 1 citation
Findings indicate that black mulberry fruit extract partially mitigates VPA-induced hepatocellular injury, primarily by enhancing glutathione-dependent antioxidant defenses.
Iza Oblak, Nebojša Pavlović, S. Vukmirović et al.· Biomolecules & biomedicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
